HGEN
Humanigen, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Cameron Durrant MBA
IPO Date
2013-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Humanigen, Inc.
CEO
Cameron Durrant MBA
IPO Date
2013-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 75,887 |
| $0.01 |
| 20 Oct 2023 | Chappell Dale | director, 10 percent owner, officer: Chief Scientific Officer | S-Sale | Disposed | 34,253 | $0.01 |
| 29 Jul 2022 | Xie Yili Kevin | director: | A-Award | Acquired | 83,418 | $0.00 |
| 29 Jul 2022 | Xie Yili Kevin | director | A-Award | Acquired | 83,418 | $0.38 |
| 29 Jul 2022 | Jordan Edward P. | director: Chief Commercial Officer | A-Award | Acquired | 455,010 | $0.00 |
| 29 Jul 2022 | BARLIANT RONALD | director: | A-Award | Acquired | 55,612 | $0.00 |
| 29 Jul 2022 | BARLIANT RONALD | director | A-Award | Acquired | 55,612 | $0.38 |
| 29 Jul 2022 | Durrant Cameron | director: Chief Executive Officer | A-Award | Acquired | 808,906 | $0.00 |
| 29 Jul 2022 | Durrant Cameron | director, officer: Chief Executive Officer | A-Award | Acquired | 808,906 | $0.38 |